The healthcare world is witnessing a major shift in blood sugar management with the introduction of GLP-1 patches. These devices offer a possibly more convenient alternative to shots of GLP-1 receptor agonists, reducing the need for daily needle pricks. The innovation delivers the drug directly through the skin, arguably enhancing person compliance